Vesicular stomatitis Indiana virus
"Vesicular stomatitis Indiana virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of VESICULOVIRUS causing a disease symptomatically similar to FOOT-AND-MOUTH DISEASE in cattle, horses, and pigs. It may be transmitted to other species including humans, where it causes influenza-like symptoms.
| Descriptor ID |
D014721
|
| MeSH Number(s) |
B04.820.455.750.900.900
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vesicular stomatitis Indiana virus".
Below are MeSH descriptors whose meaning is more specific than "Vesicular stomatitis Indiana virus".
This graph shows the total number of publications written about "Vesicular stomatitis Indiana virus" by people in this website by year, and whether "Vesicular stomatitis Indiana virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 4 | 2 | 6 |
| 2018 | 3 | 2 | 5 |
| 2019 | 1 | 0 | 1 |
| 2020 | 4 | 5 | 9 |
| 2021 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Vesicular stomatitis Indiana virus" by people in Profiles.
-
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters. J Virol. 2021 09 27; 95(20):e0059221.
-
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants. Nat Commun. 2021 07 26; 12(1):4598.
-
Inactivation of Replication-Competent Vesicular Stomatitis Virus as SARS-CoV-2 Surrogate on Common Surfaces by Disinfectants. Int J Environ Res Public Health. 2021 07 20; 18(14).
-
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection. J Vis Exp. 2021 06 05; (172).
-
Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells. STAR Protoc. 2021 03 19; 2(1):100356.
-
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Virol J. 2021 01 12; 18(1):16.
-
SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus. Viruses. 2020 12 18; 12(12).
-
Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins. Viruses. 2020 12 17; 12(12).
-
A single dose of recombinant VSV-?G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat Commun. 2020 12 16; 11(1):6402.
-
Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays. Emerg Microbes Infect. 2020 Dec; 9(1):2269-2277.